Armenta
Non-antibiotic Treatment of Mastitis in Dairy Cows
Startup A Agriculture & Food Technologies Est. 2018
Total Raised
$8.35M
A
Last Round
$4.35M
3 rounds
Investors
3
2 public
Team
3
11-50 employees
Confidence
100/100
Patents
1
About
Armenta is an agriculture technology company focused on developing novel therapies for dairy cattle diseases, with the goal of preventing the monetary losses resulting from such pathologies. Armenta focuses primarily on the non-antibiotic treatment of mastitis (infection of the cows udders). The company has developed proprietary acoustic pulse therapy (APT) technology, which has long been applied to treat inflammatory and other diseases, and related devices designed for treating dairy cows.
Classification
Sector
Agriculture & Food TechnologiesAg TechFarm Equipment & TreatmentHealth Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
SensingAcoustics
Target Customer
Agriculture & FoodLivestockBeefDairy
Business Model
B2B2CB2B
Tags
non-invasivelivestockanimal-healthdairy-farmsveterinaryfarmersagtechmedical-technologiesmedical-devices
Funding & Events
Nov 2018
A Round $4M
Undisclosed Investor(s)
Jan 2019
Undisclosed Round Undisclosed
Dragones Venture Partners
Apr 2022
Equity crowdfunding $4.35M
Together We Invest
Details
Product Stage
Alpha
Employees
11-50
Exact Count
23
District
Center District
Founded
2018
Registrar
515855385
Crunchbase
armenta
Locations
HaPnina Street 8, Ra'anana, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Sep 21, 2024
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
news, markets
Team (3)
Gil Hakim
Board Member
Chen Raizman
CEO
Gabriel Leitner
CSO
Internal
Created by
Natalia Golczar (ngolczar@gmail.com)
Created
2018-08-22T00:00:00.000Z
Last editor
Ortal Wein (ortalw@sncentral.org)